These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6788925)

  • 21. Valproic acid-induced hyperammonemia in mentally retarded adults.
    Williams CA; Tiefenbach S; McReynolds JW
    Neurology; 1984 Apr; 34(4):550-3. PubMed ID: 6422325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproate-induced lethal hyperammonaemic coma in a carrier of ornithine carbamoyltransferase deficiency.
    Tokatli A; Coşkun T; Cataltepe S; Ozalp I
    J Inherit Metab Dis; 1991; 14(5):836-7. PubMed ID: 1779634
    [No Abstract]   [Full Text] [Related]  

  • 23. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
    Mallet L; Babin S; Morais JA
    Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy.
    Honeycutt D; Callahan K; Rutledge L; Evans B
    Neurology; 1992 Mar; 42(3 Pt 1):666-8. PubMed ID: 1549234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum carnitine, beta-hydroxybutyrate and ammonia levels during valproic acid therapy.
    Toksoy HB; Tanzer FN; Atalay A
    Turk J Pediatr; 1995; 37(1):25-9. PubMed ID: 7732605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproate as a cause of hyperammonemia in heterozygotes with ornithine-transcarbamylase deficiency.
    Leão M
    Neurology; 1995 Mar; 45(3 Pt 1):593-4. PubMed ID: 7898728
    [No Abstract]   [Full Text] [Related]  

  • 27. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproic acid-associated encephalopathy with coma.
    Settle EC
    Am J Psychiatry; 1995 Aug; 152(8):1236-7. PubMed ID: 7625483
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute changes of blood ammonia may predict short-term adverse effects of valproic acid.
    Zaccara G; Campostrini R; Paganini M; Moroni F; Valenza T; Targioni G; Arnetoli G; Zappoli R; Baruzzi A
    Neurology; 1984 Nov; 34(11):1519-21. PubMed ID: 6436733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood ammonia levels in epileptic children on 2 dose ranges of valproic acid monotherapy: a cross-sectional study.
    Sharma S; Gulati S; Kabra M; Kalra V; Vasisht S; Gupta YK
    J Child Neurol; 2011 Jan; 26(1):109-12. PubMed ID: 20921570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standardization in VPA-induced hyperammonemia.
    Zaret BS; Marini AM
    Neurology; 1985 Jan; 35(1):136-7. PubMed ID: 3917561
    [No Abstract]   [Full Text] [Related]  

  • 32. A mechanism for valproate-induced hyperammonemia.
    Coude FX; Rabier D; Cathelineau L; Grimber G; Parvy P; Kamoun PP
    Pediatr Res; 1981 Jun; 15(6):974-5. PubMed ID: 6787550
    [No Abstract]   [Full Text] [Related]  

  • 33. [Isolated hyperammonemia. A frequent consequence of treatment with sodium valproate].
    Warter JM; Marescaux C; Rumbach L; Galmiche J; Micheletti G; Koehl C; Imler M
    Nouv Presse Med; 1981 Nov; 10(41):3406-7. PubMed ID: 6795590
    [No Abstract]   [Full Text] [Related]  

  • 34. Reversible valproic acid-induced dementia: a case report.
    Zaret BS; Cohen RA
    Epilepsia; 1986; 27(3):234-40. PubMed ID: 3084231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproate acute administration, EEG epileptic abnormalities, and ammonemia.
    Sannita WG
    Neurology; 1992 Oct; 42(10):2003-5. PubMed ID: 1407583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction.
    Zaret BS; Beckner RR; Marini AM; Wagle W; Passarelli C
    Neurology; 1982 Feb; 32(2):206-8. PubMed ID: 6798491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sodium valproate, hyperammonemia and hepatic encephalopathy].
    Imler M; Warter JM; Marescaux C
    Gastroenterol Clin Biol; 1982 Dec; 6(12):1042. PubMed ID: 6819177
    [No Abstract]   [Full Text] [Related]  

  • 38. Hyperammonemia following intravenous valproate loading.
    DeWolfe JL; Knowlton RC; Beasley MT; Cofield S; Faught E; Limdi NA
    Epilepsy Res; 2009 Jul; 85(1):65-71. PubMed ID: 19299111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherited and acquired syndromes of hyperammonemia and encephalopathy in children.
    Treem WR
    Semin Liver Dis; 1994 Aug; 14(3):236-58. PubMed ID: 7939785
    [No Abstract]   [Full Text] [Related]  

  • 40. [Encephalopathy with asterixis induced by sodium valproate. Role of hyperammonemia without hepatic insufficiency].
    Gastaut JL; Mege JL
    Presse Med; 1985 Feb; 14(7):431. PubMed ID: 3157141
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.